Large - scale cancer
sequencing efforts such as TCGA and ICGC have catalogued somatic mutations in a variety of common cancer types.
Not exact matches
Carr is leading one of the NASA
sequencing efforts, and Johnson's technique could increase
such a tool's usefulness.
As large - scale genome
sequencing projects,
such as the Human Genome Project, near completion, the research community's focus is shifting toward
efforts to determine functional information about these
sequenced genes.
Even as
sequencing costs decline,
such high - throughput
efforts require pooling the DNA samples.
By better understanding the limitations of genome - wide
sequencing, Vogelstein notes, researchers and policymakers might be better able to direct funding and
efforts to areas,
such as Alzheimer's disease, where a person's genetic profile might have a very real effect on their likelihood of getting the disease.
If
such efforts succeed, says Robert Waterston, a geneticist who heads the genome
sequencing center at Washington University in St. Louis, Missouri, the technique «could be the start of something impressive.»
It has launched projects
such as a major
effort to develop knock - out mice (ScienceNOW, 7 September 2006) and The Cancer Genome Atlas (Science, 16 December 2005, p. 1751), which, with the cancer institute, is
sequencing mutations in human cancers.
She has contributed to widely varying fields —
such as viral
sequencing, information theory, rural disease surveillance, and education
efforts in West Africa — to create comprehensive approaches for detecting, containing, and treating deadly infectious diseases.
Research Focus: I dedicate my time and
effort to develop high - throughput
sequencing technologies
such as single cell transcriptomic, ChIP - Seq, ChIA - PET, and many more... The scientific rational is to understand better and with a different angle, the mechanisms of epigenetic regulation of gene expression in (rare) immune cells, pathologically relevant in many diseases
such as asthma, SLE, tuberculosis...
As highlighted in the final print issue of Genome Technology, investigators leading clinical
sequencing efforts have faced ethical dilemmas already,
such as the return of genetic information to family members in the event that a patient dies.
Topics that will be explored include: • Cellular and developmental origins of pediatric cancer • Key findings of pan-cancer analysis
efforts • Computational pipelines to analyze large - scale
sequencing data • Opportunities for leveraging existing cancer genomics datasets • Strategies for integrative analysis of germline and somatic variants • Correlation of germline / somatic variation to clinical features
such as tumor subtype.
A discombobulated
effort with
such distinctive
sequences, it fails to maintain a full arc.
Tools to assist in the process are available (Devaney, O'Brien, Resnik, Keister, & Weissberg, 2006), and it can be helpful to compare with CASEL's scope and
sequence chart of SEL activities across grade levels (Elias et al., 1997, Appendix A) and comprehensive frameworks that have resulted from
such an assessment process (e.g., Anchorage School District, 2013) in orienting one's
efforts.